+32.9%
CVS vs EXE
+5.1%
+27.8%
-16.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | EXE | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.1% | +0.3% | -0.4% | -0.1% |
| 7D | -2.0% | -2.2% | +0.2% | -1.8% |
| 30D | +1.9% | -0.8% | +2.7% | +2.0% |
| 3M | -2.2% | +10.0% | -12.2% | -3.0% |
| 6M | +26.7% | -6.3% | +33.1% | +27.6% |
| YTD | +22.9% | -10.7% | +33.6% | +24.7% |
| 1Y | +32.9% | +2.7% | +30.2% | +30.8% |
| All | +32.9% | +5.1% | +27.8% | +30.8% |
Cumulative growth
Daily Returns
Daily percentage return beside EXE.
Daily Out/Under-Performance
Portfolio return minus EXE return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EXE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded EXE wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling